Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid SThree (STEM) by Steve Moore in ShareProphets
- Buy Marks & Spencer Group (MKS) by Citi
- Neutral AIB Group (CDI) (AIBG) by Goldman Sachs
- Avoid Intercede Group (IGP) by Steve Moore in ShareProphets
- Watch Hays (HAS) by Jon Smith in The Motley Fool
- Buy Trustpilot Group (TRST) by Deutsche Bank
- Buy IP Group (IPO) by Deutsche Bank
- Sell Liontrust Asset Management (LIO) by Deutsche Bank
- Buy Bank of Ireland Group (CDI) (BIRG) by Goldman Sachs
- Buy Trustpilot Group (TRST) by Berenberg
- Buy Fisher (James) & Sons (FSJ) by Berenberg
- Underperform Liontrust Asset Management (LIO) by RBC Capital
- Neutral Victrex plc (VCT) by JP Morgan
- Hold National Grid (NG.) by Jefferies
- Buy SSE (SSE) by Jefferies
- Buy easyJet (EZJ) by William Kay in The Times - Tempus
- Hold Ryanair Holdings (CDI) (0RYA) by William Kay in The Times - Tempus
- Avoid Ten Lifestyle Group (TENG) by Steve Moore in ShareProphets
- Buy RM (RM.) by Hot Stock Rockets in ShareProphets
- Avoid Beeks Financial Cloud Group (BKS) by Steve Moore in ShareProphets
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,440 open tips for GSK (GSK)
| Latest Bid : 1,959.00p | Latest Ask : 1,960.00p |
| High Today : 2,014.00p | Low Today : 1,945.50p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 6,038,852 | MKT Cap : £81760.13M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Harvey Jones | Premium Only | 2024-06-30 08:00:00 30/06/2024 | 29.81% |
| Buy | Robert Stephens (Telegraph) | Premium Only | 2024-06-27 20:00:00 27/06/2024 | 28.33% |
| Buy | Jefferies | Premium Only | 2024-06-27 11:46:00 27/06/2024 | 38.43% |
| Buy | Citi | Premium Only | 2024-06-24 17:46:00 24/06/2024 | 30.88% |
| Buy | Deutsche Bank | Premium Only | 2024-06-18 09:21:00 18/06/2024 | 21.60% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.52% | 16/03/2026 |
| Latest Bid : 1,959.00p | Latest Ask : 1,960.00p |
| High Today : 2,014.00p | Low Today : 1,945.50p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 6,038,852 | MKT Cap : £81760.13M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Harvey Jones | Premium Only | 2024-06-30 08:00:00 30/06/2024 | 29.81% |
| Buy | Robert Stephens (Telegraph) | Premium Only | 2024-06-27 20:00:00 27/06/2024 | 28.33% |
| Buy | Jefferies | Premium Only | 2024-06-27 11:46:00 27/06/2024 | 38.43% |
| Buy | Citi | Premium Only | 2024-06-24 17:46:00 24/06/2024 | 30.88% |
| Buy | Deutsche Bank | Premium Only | 2024-06-18 09:21:00 18/06/2024 | 21.60% |